Surgical management of XXXX .

@entity1 @entity5 @entity0
INTRODUCTION: Selected @entity1 with isolated @entity0 ( @entity0 ) may benefit from surgical management; however, indications remain unclear and the risks may outweigh the benefits in @entity1 with a generally poor prognosis. METHODS: Between 1998 and 2006, 17 @entity1 diagnosed with @entity0 were considered for surgical management (<4 @entity5 , @entity5 <4 cm in diameter and no/stable extrahepatic metastases). Peri-operative and outcomes data were analysed and compared. RESULTS: Eight @entity1 were found to have extensive or untreatable disease on staging laparoscopy and intra-operative ultrasound (SL/IOUS). The remaining nine @entity1 underwent surgical management [seven laparoscopic radiofrequency ablations (RFA) and two hepatic resections]. Median length of follow-up for @entity1 treated surgically was 40.0 months, median disease-free survival (DFS) was 32.2 months and median time to disease progression was 17.7 months. Of the eight @entity1 not amenable to surgery, median length of follow-up was 21.8 months. CONCLUSION: SL/IOUS prevented unnecessary laparotomy in half of the @entity1 taken to the operating room for surgical treatment of @entity0 . In @entity1 with @entity0 , SL/IOUS should be considered standard of care before surgical intervention. The small number of @entity1 and short follow-up may be inadequate to determine the true value of surgical management in this group of @entity1 with @entity0 .
